Featured Product
This Week in Quality Digest Live
Quality Insider Features
Richard Harpster
Good news? You are probably already doing it.
Adam Zewe
Researchers find the root cause of side-channel attacks that are easy to implement but difficult to detect
Constance Noonan Hadley
The time has come to check whether the benefits of teamwork still outweigh the costs
Lily Chen
The cornerstone of cybersecurity
Jeremy L. Boerger
To keep your business running, you need visibility into your IT assets

More Features

Quality Insider News
New standard leads to smoother production in 3D printing
Making designs a physical reality with the know-how to make more
Sapphire XC will ship in late Q3 beginning with aerospace companies
Major ERP projects take six months longer than companies were told
Program inspires leaders to consider systems perspective for continuous improvement and innovation
Collaboration produces online software for collecting quality inspection data
Serving the needs of employers and educators
Powder reuse schemes affect medical device performance

More News

Quality Digest

Quality Insider

New Standard to Help Diagnose Heart Attacks

Published: Sunday, May 23, 2004 - 22:00

Diagnosing heart attacks may become an even more precise science with the advent of the first of a series of new clinical standards issued by the National Institute of Standards and Technology.

Standard Reference Material 2921--human cardiac troponin complex--is intended to help manufacturers develop and calibrate assays that measure specific protein concentrations in patient blood samples to determine whether a heart attack has occurred.

The SRM is a solution containing certified concentrations of three related proteins including cardiac troponin I, purified from human heart tissue from cadavers. Users can calibrate their assays by analyzing the SRM and comparing the results to the NIST-certified value for troponin I. The standard is expected to help reduce variations in clinical test results from as much as 50-fold on the same sample to twofold. "It’s a big first step toward getting the system under control," says Michael Welch, leader of the NIST development team.

Although NIST already produces more than 60 SRMs for the clinical diagnostics community, this is the first designed to help measure concentrations of large, protein-based health status markers. Troponin I is difficult to measure because it can exist in low concentrations and in different chemical forms, sometimes attached to other related proteins. NIST is developing additional standards and methods for measuring other health-status indicators of this type, including hormones used to assess thyroid function and other markers for heart attack risk.

SRM 2921 is intended to help U.S. makers of in vitro diagnostic medical devices sell their products in Europe. A European Union directive requires that such devices be calibrated with standards that are traceable to internationally recognized certified reference materials or procedures. SRM 2921 has been nominated for inclusion on the international list of higher-order reference materials. The list currently contains approximately 150 entries for 96 health status markers; NIST SRMs provide traceability for 72 of these.

For more information, click here.

Discuss

About The Author

Quality Digest’s picture

Quality Digest

For 40 years Quality Digest has been the go-to source for all things quality. Our newsletter, Quality Digest, shares expert commentary and relevant industry resources to assist our readers in their quest for continuous improvement. Our website includes every column and article from the newsletter since May 2009 as well as back issues of Quality Digest magazine to August 1995. We are committed to promoting a view wherein quality is not a niche, but an integral part of every phase of manufacturing and services.